UK gene therapy consortium: state of play

E. Alton (London, United Kingdom)

Source: Annual Congress 2004 - New approaches to cystic fibrosis: from cells and molecules to novel therapies
Session: New approaches to cystic fibrosis: from cells and molecules to novel therapies
Session type: Assembly Symposium
Number: 4025

Slide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Alton (London, United Kingdom). UK gene therapy consortium: state of play. Annual Congress 2004 - New approaches to cystic fibrosis: from cells and molecules to novel therapies

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Genes, environments, development and asthma: a reappraisal
Source: Eur Respir J 2007; 29: 179-184
Year: 2007



SNPs in SPINK5 gene region are associated with asthma severity: Preliminary results from the gene environment interactions in respiratory diseases (GEIRD) study
Source: Annual Congress 2013 –Genetic factors in airway development and disease
Year: 2013

Organising a European spirometry training programme including: role of the course director and the application process
Source: School Course 2014 - European Spirometry Train-the-Trainer Course
Year: 2014


The crucial role of the expression of negative regulator of gene transcription SOCS5 in asthma pathogenesis
Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making
Year: 2013

The philadelphia public schools reorganization: did asthma play a role?
Source: Eur Respir J 2003; 22: Suppl. 45, 135s
Year: 2003

Clinical use of new and repurposed drugs: the role and contribution of the ERS collaborative projects
Source: International Congress 2017 – In the frontline of the fight against tuberculosis
Year: 2017


What role can medical professionals play in the development and regulation of medical technology?
Source: Research Seminar 2015 - Personalising respiratory care in Europe
Year: 2015

Association of glucocorticoid receptor gene polymorphism with asthma in the Volga-Ural region of Russia
Source: International Congress 2014 – Genetics and environmental factors underlying asthma and COPD
Year: 2014


Astro-Lab project: Assessment of the safety of long-acting beta agonists (LABAs) in asthma by combining health-care databases and direct patient follow-up: Description of the patient pattern in France and in the United-Kingdom (UK)
Source: Annual Congress 2013 –Treatment and adherence to treatment of respiratory disease
Year: 2013


National and international expansion of capacity building model of India for primary care physicians(PCPs) in the management of COPD & Asthma
Source: International Congress 2018 – Primary care management of COPD
Year: 2018

The role of gene–environment interactions in lung disease: the urgent need for the exposome
Source: Eur Respir J, 55 (2) 1902064; 10.1183/13993003.02064-2019
Year: 2020



SWAAS - The first state level public health program for COPD and Asthma in India - an early evaluation>
Source: Virtual Congress 2020 – Organising respiratory disease management in primary care
Year: 2020


Redefining the asthma treatment paradigm using a locally administered dual PI3Kgd inhibitor
Source: International Congress 2016 – New therapies and therapeutic targets
Year: 2016



Association between candidate gene polymorphisms and asthma severity in adults. A Bayesian analysis
Source: International Congress 2016 – Role of genetics and exposures in COPD and asthma
Year: 2016

Pulmonologists and lung cancer: pivotal role in multidisciplinary approach
Source: Eur Respir J 2013; 42: 1183-1185
Year: 2013